簡要描述:干擾素調(diào)節(jié)因子8抗體免 疫 原;KLH conjugated synthetic peptide derived from human IRF8: 31-130/426
產(chǎn)品分類
Product Category相關(guān)文章
Related Articles詳細(xì)介紹
干擾素調(diào)節(jié)因子8抗體
產(chǎn)品名稱 | 英文名稱 | 貨號 |
干擾素調(diào)節(jié)因子8抗體 | IRF8 | GOY-01K2547 |
商品屬性:
英文名稱: IRF8
中文名:干擾素調(diào)節(jié)因子8抗體
別 名;H ICSBP; H-ICSBP;
HGNC:5358; HICSBP; ICSBP 1; ICSBP; ICSBP1; Interferon consensus sequence
binding protein 1; Interferon consensus sequence binding protein; Interferon
consensus sequence-binding protein; Interferon regulatory factor 8; IRF 8;
IRF-8; Irf8; IRF8_HUMAN; MYLS.
研究領(lǐng)域;細(xì)胞生物 轉(zhuǎn)錄調(diào)節(jié)因子 表觀遺傳學(xué) 泛素
抗體來源;Rabbit
克隆類型;Polyclonal
交叉反應(yīng);(predicted:
Human, Mouse, Rat, Chicken, Pig, Cow, Horse, Rabbit, Sheep, )
產(chǎn)品應(yīng)用;ELISA=1:5000-10000
IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in
other applications.
optimal
dilutions/concentrations should be determined by the end user.
理論分子量;48kDa
細(xì)胞定位;細(xì)胞核
性 狀;Liquid
濃 度;1mg/ml
免 疫 原;KLH
conjugated synthetic peptide derived from human IRF8: 31-130/426
亞 型;IgG
純化方法;affinity purified
by Protein A
緩 沖 液;0.01M
TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
注意事項(xiàng);This
product as supplied is intended for research use only, not for use in human,
therapeutic or diagnostic applications.
產(chǎn)品介紹:
Interferon consensus sequence-binding protein
(ICSBP) is a transcription factor of the interferon (IFN) regulatory factor
(IRF) family. Proteins of this family are composed of a conserved DNA-binding
domain in the N-terminal region and a divergent C-terminal region that serves
as the regulatory domain. The IRF family proteins bind to the IFN-stimulated
response element (ISRE) and regulate expression of genes stimulated by type I
IFNs, namely IFN-alpha and IFN-beta. IRF family proteins also control
expression of IFN-alpha and IFN-beta-regulated genes that are induced by
viral infection. [provided by RefSeq, Jul 2008] Specifically binds to the upstream regulatory
region of type I IFN and IFN-inducible MHC class I genes (the interferon
consensus sequence (ICS)). Plays a negative regulatory role in cells of the
immune system. |
多克隆抗體制備:
我公司合成抗原,保證陽性血清和抗體ELISA效價(jià)達(dá)到1:32000,由蛋白抗原制備的多抗,保證WB檢測結(jié)果是陽性。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
鼠單克隆抗體制備:
客戶可根據(jù)項(xiàng)目實(shí)際需求情況靈活選擇進(jìn)行,我公司將為您的項(xiàng)目提供專業(yè)的建議。在制備過程中,與客戶互動(dòng)驗(yàn)證,確保最終制備的抗體ELISA陽性血清檢測達(dá)到合同要求的同時(shí),也能滿足客戶抗體最終應(yīng)用驗(yàn)證需求。技術(shù)服務(wù)實(shí)行分步報(bào)價(jià),按節(jié)點(diǎn)收費(fèi),為客戶節(jié)約成本。
重組抗體表達(dá)服務(wù):
重組抗體技術(shù)使制備人源化抗體和人源抗體成為可能,而這是其他常規(guī)的多克隆或單克隆抗體制備方法無法做到的。我公司已搭建好的抗體測序、重組抗體表達(dá)等先進(jìn)平臺,能為客戶提供各種類型的重組抗體表達(dá)服務(wù),包含鼠源單克隆抗體構(gòu)建及表達(dá)、更換恒定區(qū)亞型的嵌合抗體表達(dá),抗體人源化改造及表達(dá)等服務(wù)。
單項(xiàng)免疫學(xué)及檢測服務(wù):
我公司也為客戶提供單項(xiàng)免疫學(xué)和檢測服務(wù),如動(dòng)物免疫、動(dòng)物飼養(yǎng)、抗體修飾服務(wù)(如FITC,HRP等的標(biāo)記)、以及ELISA,WB,IHC,DB等檢測服務(wù)。
抗體定制服務(wù):
已注冊商標(biāo),主要用于抗體藥物發(fā)現(xiàn)和開發(fā),是我公司針對有特定應(yīng)用要求和各種模型測試的客戶量身定制的專業(yè)服務(wù),主要面向工業(yè)客戶。
產(chǎn)品咨詢
歡迎您關(guān)注我們的微信了解更多信息
電話
微信掃一掃